Transcranial direct current stimulation in obsessive-compulsive disorder: an update in electric field modeling and investigations for optimal electrode montage

Nenhuma Miniatura disponível
Citações na Scopus
12
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
TAYLOR & FRANCIS LTD
Autores
STERN, Emily
MEZGER, Eva
PADBERG, Frank
D'URSO, Giordano
Citação
EXPERT REVIEW OF NEUROTHERAPEUTICS, v.19, n.10, p.1025-1035, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: Transcranial Direct Current Stimulation (tDCS) is a non-invasive brain stimulation intervention that has been investigated for several psychiatric disorders, including Obsessive-Compulsive Disorder (OCD). As there are several candidate brain regions for targeting OCD relevant networks, clinical studies using tDCS have considerably varied in terms of the electrode montages used. Computer modeling of electric field currents induced by tDCS can help guiding the research of relevant targets for OCD. In this review, the authors used this tool to investigate targeted brain areas from previous studies of tDCS in OCD. Areas covered: A literature search for articles with the keywords 'tDCS', 'Transcranial Direct Current Stimulation' and 'Obsessive Compulsive Disorder' was conducted to identify relevant publications. For comparing different electrode montages, electric field (EF) models were performed using high-resolution brain scan templates. Authors found 13 studies mostly showing an improvement in OCD symptoms. The electrode montages varied considerably between studies. Nonetheless, two main patterns of EFs could be identified: 'focal montages', with EFs concentrated in the prefrontal cortex, and 'diffuse montages', with widespread EFs over cortical areas. Expert opinion: Electric field simulation can guide future clinical trials in psychiatry, using personalized tDCS montages with distinct electrode positioning according to clusters of symptoms
Palavras-chave
Obsessive-compulsive disorder, tDCS, neuromodulation, electric field, computer modeling
URI
https://observatorio.fm.usp.br/handle/OPI/34089
Referências
  1. Ahmari SE, 2013, SCIENCE, V340, P1234, DOI 10.1126/science.1234733
  2. ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119
  3. Alizadeh Goradel J., 2016, DISORDER PRACT CLIN, V4, P75, DOI [10.15412/J.JPCP.06040201, DOI 10.15412/J.JPCP.06040201]
  4. American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU
  5. BAJBOUJ M, 2014, EUR ARCH PSY CLIN N, V264, P27
  6. Bation R, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.10.001
  7. BAXTER LR, 1994, J CLIN PSYCHIAT, V55, P54
  8. Bikson M, 2018, BRAIN STIMUL, V11, P465, DOI 10.1016/j.brs.2017.12.008
  9. Brown C, 2019, J PSYCHIATR RES, V109, P68, DOI 10.1016/j.jpsychires.2018.11.018
  10. Brunoni AR, 2017, JAMA PSYCHIAT, V74, P143, DOI 10.1001/jamapsychiatry.2016.3644
  11. Brunoni AR, 2016, BRIT J PSYCHIAT, V208, P522, DOI 10.1192/bjp.bp.115.164715
  12. Brunoni AR, 2014, EXPERT REV MED DEVIC, V11, P383, DOI 10.1586/17434440.2014.911082
  13. Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002
  14. Brunoni AR, 2017, N ENGL J MED
  15. Brunoni AR, 2018, BRAZILIAN J PSYCHIAT
  16. Carmi L, 2018, BRAIN STIMUL, V11, P158, DOI 10.1016/j.brs.2017.09.004
  17. Csifcsak G, 2018, J AFFECT DISORDERS, V234, P164, DOI 10.1016/j.jad.2018.02.077
  18. D'Urso G, 2018, J ECT, V34, P172, DOI 10.1097/YCT.0000000000000538
  19. D'Urso G, 2017, J AFFECT DISORDERS, V219, P25, DOI 10.1016/j.jad.2017.05.019
  20. D'Urso G, 2016, DEPRESS ANXIETY, V33, P1132, DOI 10.1002/da.22578
  21. D'Urso G, 2016, NEUROCASE, V22, P60, DOI 10.1080/13554794.2015.1045522
  22. D'Urso G, 2012, J ECT, V28, P190, DOI 10.1097/YCT.0b013e3182542649
  23. de Morton NA, 2009, AUST J PHYSIOTHER, V55, P129, DOI 10.1016/S0004-9514(09)70043-1
  24. de Vries FE, 2014, BIOL PSYCHIAT, V76, P878, DOI 10.1016/j.biopsych.2013.11.021
  25. Dedoncker J, 2016, BRAIN STIMUL, V9, P501, DOI 10.1016/j.brs.2016.04.006
  26. Del Casale A, 2011, NEUROPSYCHOBIOLOGY, V64, P61, DOI 10.1159/000325223
  27. Dinn W. E., 2016, NEUROLOGY PSYCHIAT B, V22, P146, DOI [10.1016/j.npbr.2016.08.003, DOI 10.1016/J.NPBR.2016.08.003]
  28. Dunlop K, 2016, NEUROPSYCHOPHARMACOL, V41, P1395, DOI 10.1038/npp.2015.292
  29. da Silva RDF, 2016, SAO PAULO MED J, V134, P446, DOI 10.1590/1516-3180.2016.0155010716
  30. Ferrao YA, 2012, PSYCHIAT RES, V197, P253, DOI 10.1016/j.psychres.2011.09.017
  31. GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006
  32. Harrison BJ, 2009, ARCH GEN PSYCHIAT, V66, P1189, DOI 10.1001/archgenpsychiatry.2009.152
  33. Hazari N, 2016, J ECT, V32, P144, DOI 10.1097/YCT.0000000000000309
  34. Hirschtritt ME, 2017, JAMA-J AM MED ASSOC, V317, P1358, DOI 10.1001/jama.2017.2200
  35. Iwaihara Y, 2015, ANTICANCER RES, V35, P4419
  36. Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015
  37. Lee JC, 2009, COMPR PSYCHIAT, V50, P431, DOI 10.1016/j.comppsych.2008.11.007
  38. Lee WH, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00048
  39. Lefaucheur JP, 2017, CLIN NEUROPHYSIOL, V128, P56, DOI 10.1016/j.clinph.2016.10.087
  40. MacMaster F, 2010, PSYCHIAT RES-NEUROIM, V181, P97, DOI 10.1016/j.pscychresns.2009.08.005
  41. Mantovani A, 2006, INT J NEUROPSYCHOPH, V9, P95, DOI 10.1017/S1461145705005729
  42. Mantovani A, 2010, INT J NEUROPSYCHOPH, V13, P217, DOI 10.1017/S1461145709990435
  43. Miguel EC, 2000, J CLIN PSYCHIAT, V61, P150, DOI 10.4088/JCP.v61n0213
  44. Moffa AH, 2018, PSYCHIAT CLIN N AM, V41, P447, DOI 10.1016/j.psc.2018.05.002
  45. Mondino M, 2015, J ECT, V31, P271, DOI 10.1097/YCT.0000000000000218
  46. Mondino M, 2015, CURR PHARM DESIGN, V21, P3373, DOI 10.2174/1381612821666150619093648
  47. Najafi K., 2017, INDIAN J PSYCHOL MED, V39, P573, DOI [10.1016/j.brs.2017.01.081, DOI 10.4103/IJPSYM.IJPSYM_388_16]
  48. Nih Od Ocpl, 2014, BRAIN 2025 SCI VIS
  49. Nitsche MA, 2009, BIOL PSYCHIAT, V66, P503, DOI 10.1016/j.biopsych.2009.03.022
  50. Opitz A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31236
  51. Palm U, 2017, NEUROCASE, V23, P173, DOI 10.1080/13554794.2017.1319492
  52. Pedro Franz A, 2013, TRENDS PSYCHIAT PSYC
  53. Rehn S, 2018, PSYCHIAT QUART, V89, P645, DOI 10.1007/s11126-018-9566-7
  54. Rosario MC, 2009, CNS SPECTRUMS, V14, P315, DOI 10.1017/S1092852900020319
  55. Rotge JY, 2008, J PSYCHIATR NEUROSCI, V33, P405
  56. Ruscio AM, 2010, MOL PSYCHIATR, V15, P53, DOI 10.1038/mp.2008.94
  57. Sauvaget A, 2018, J ECT, V34, P211, DOI 10.1097/YCT.0000000000000513
  58. Saxena S, 2002, ARCH GEN PSYCHIAT, V59, P250, DOI 10.1001/archpsyc.59.3.250
  59. Senco NM, 2015, EXPERT REV MED DEVIC, V12, P381, DOI 10.1586/17434440.2015.1037832
  60. Shah Dhwani B, 2008, Psychiatry (Edgmont), V5, P24
  61. Shavitt RG, 2006, COMPR PSYCHIAT, V47, P278, DOI 10.1016/j.comppsych.2005.09.001
  62. Simpson HB, 2006, J CLIN PSYCHIAT, V67, P269, DOI 10.4088/JCP.v67n0214
  63. Snyder HR, 2015, CLIN PSYCHOL SCI, V3, P301, DOI 10.1177/2167702614534210
  64. Starcevic V, 2008, AUST NZ J PSYCHIAT, V42, P651, DOI 10.1080/00048670802203442
  65. Subira M, 2015, J PSYCHIATR NEUROSCI, V40, P232, DOI 10.1503/jpn.140118
  66. To WT, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00128
  67. Trevizol AP, 2016, J ECT, V32, P262, DOI 10.1097/YCT.0000000000000335
  68. Vaghi MM, 2017, BIOL PSYCHIAT, V81, P708, DOI 10.1016/j.biopsych.2016.08.009
  69. van den Heuvel OA, 2016, EUR NEUROPSYCHOPHARM, V26, P810, DOI 10.1016/j.euroneuro.2015.12.005
  70. VOELKER R, 2018, JAMA-J AM MED ASSOC, V320, P1098, DOI 10.1001/JAMA.2018.13301
  71. Volpato C, 2013, NEUROCASE, V19, P360, DOI 10.1080/13554794.2012.667131
  72. Yavari F, 2018, NEUROSCI BIOBEHAV R, V85, P81, DOI 10.1016/j.neubiorev.2017.06.015
  73. Yekta M, 2015, PRACTICE CLIN PSYCHO, V3, P185

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPS
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/IPq
Artigos e Materiais de Revistas Científicas - LIM/23
Artigos e Materiais de Revistas Científicas - LIM/27